PLoS ONE · 2014 · 130 citations · 28 references
Serum levels of Gd-IgA1-specific antibodies are elevated in most IgAN patients, and their assessment, together with serum levels of Gd-IgA1, improves the specificity of the assays. Our observations suggest that a panel of serum biomarkers may be helpful in differentiating IgAN from other glomerular diseases.
28
ANew Look at the Statistical Model Identification
HlROTUGU AKAlKE · 2011 · 4.2K citations
Parameter Estimation, Engineering, Statistical Foundation +17
The Commonest Glomerulonephritis in the World: IgA Nephropathy
Giuseppe D’Amico · QJM · 1987 · 870 citations